The plectrum (benfluorex) was marketed in France from 1975 to November 2009 , when he was finally banned by Afssaps through the struggles of a pulmonologist Brest Irene Frachon.
This book is the story of a fight to ban the 150 mg Picks: In November 2009, after a thorough investigation of several years, Irene Frachon, aided by fellow of the University Hospital of Brest, had contributed to the prohibition of the drug. normally prescribed to treat diabetes which was taken by 300,000 patients in France, it was administered as an appetite suppressant to millions of people. However, it is not safe and can cause death: This medication may cause in some people, serious side effects. Brest physicians were able to prove that the Picks could lead to serious complications in heart valves or pulmonary hypertension. But also death.
Frachon Irene tells his investigation, his interventions Afssaps, its relations with the laboratory, which markets the drug, its discoveries.
Servier Laboratory (second after the French pharmaceutical group Sanofi-Aventis) was assigned an interim publisher (dialogues.fr-editions): This is just proof that the giant pharmaceutical royally fucks Health people indeed his only interest is profitability.
There are significant conflicts of interest, especially in the expert committees Afssaps. Agencies are not doing enough to sort out the independent experts and those who publish through the pharmaceutical industry Indeed, experts who have a conflict of interest should not participate in drug reviews.
I note that the pick is a derivative of FLUOR and the icing on the cake is a recent study has confirmed the dangers the pick, it is about a thousand dead (personally I would say several thousand).
I ask the pharmaceutical industry to stop developing drugs based Fluor, which only serve to recycle toxic waste become profitable.
... We must pass the Knowledge and Truth ...
... The truth will come to know ...
DJAMELITO
0 comments:
Post a Comment